Sectors

BIO
Bio-Rad Laboratories, Inc.
355.05
1 x 352.99
1 x 353.67
bid
ask
+
0.51
0.14%
09:36 AM
timesize
Ytd17.18%
1y34.38%
349.37
day range
355.05
236.73
52 week range
355.85
Open349.37Prev Close354.54Low349.37High355.05Mkt Cap9.56B
Vol1.93KAvg Vol365.78KEPS9.28P/E38.26Forward P/E35.15
Beta1.06Short Ratio3.09Inst. Own92.36%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg304.85200-d Avg296.581yr Est329.00
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-292026-092.23N/AN/AN/A
2026-08-042026-061.752.620.8749.71%
2026-04-302026-031.971.89-0.08-4.06%
2026-02-122025-122.572.51-0.06-2.33%
2025-10-292025-092.32.26-0.04-1.74%
2025-07-312025-061.932.610.6835.23%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-07RBC CapitalUpgradeOutperformOutperform
2026-08-05CitigroupUpgradeNeutralNeutral
2026-08-05RBC CapitalUpgradeOutperformOutperform
2026-08-05Wells FargoUpgradeEqual-WeightEqual-Weight
2026-05-01Wells FargoUpgradeEqual-WeightEqual-Weight
2026-04-07CitigroupDowngradeBuyNeutral
Profile
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Holder
DateNameRelationQuantityDescription
2025-09-04ALLISON SCHWARTZDirector1.46KConversion of Exercise of derivative security
2025-09-04COREY COLLEENOfficer19.55KConversion of Exercise of derivative security
2025-03-13CROWLEY MICHAEL WOfficer8.17KSale
2025-10-23DIVINCENZO JONATHAN PPresident919.00Conversion of Exercise of derivative security
2025-10-19EVRAN SEDATOfficer2.23KConversion of Exercise of derivative security
2026-04-20HINCKLEY GREGORY KDirector1.22KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29First Eagle Investment Management, LLC2.61M924.90M12.02%
2026-06-29Blackrock Inc.1.70M602.92M7.84%
2026-03-30Dimensional Fund Advisors LP1.09M386.58M5.03%
2026-03-30Vanguard Capital Management LLC831.17K294.96M3.83%
2026-03-30Vanguard Portfolio Management LLC829.19K294.26M3.83%
2026-03-30Ariel Investments, LLC785.96K278.92M3.63%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-04-29First Eagle Funds-First Eagle Global Fund1.88M666.73M8.67%
2026-03-30SmallCap World Fund Inc756.04K268.30M3.49%
2026-07-30iShares Trust-iShares Core S&P Mid-Cap ETF618.66K219.55M2.85%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund593.23K210.53M2.74%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund429.73K152.50M1.98%
2026-03-30Ariel Investment Trust-Ariel Fund333.11K118.21M1.54%
Split
SplitDate
2 : 12002-03-08
3 : 21996-06-03
3 : 21986-06-11
1 : 11986-06-10
3 : 21985-08-01
1 : 11985-07-31